Pulmonary Function Testing (PFT) is a complete evaluation of the respiratory system including patient history, physical examinations, chest x-ray examinations, arterial blood gas analysis, and tests of pulmonary function.
The primary purpose of pulmonary function testing is to identify the severity of pulmonary impairment. Pulmonary function testing has diagnostic and therapeutic roles and helps clinicians answer some general questions about patients with lung disease.
Europe's sales volume accounted for the highest market share (28.23%) in 2016, followed by the North America and China.
At present, the manufactures of Pulmonary Function Testing Systems are concentrated in North America, Europe, China and Japan. Europe is the largest production area in the world, which occupied about 31.42% production share in 2016. The global leading players in this market are CareFusion(BD), Schiller, CHEST, COSMED, nSpire Health, NDD MGC Diagnostics, etc.
The Pulmonary Function Testing Systems are mainly used by Hospitals, Physical Examination Center and Physician Groups. The dominant application of Pulmonary Function Testing Systems is Hospitals.
In the last few years, the total number of high-tech Pulmonary Function Testing Systems developed by domestic manufacturers is limited. This shows that the efforts to develop high-tech product in China is not enough, but also shows that the allocation space of domestic Pulmonary Function Testing Systems still need to expand. There is still a big gap compared with the imported Pulmonary Function Testing Systems.
Despite the presence of competition problems, as large demand of high-tech products at home and abroad, many companies began to enter the field of high-tech, emergence of technological advancements, investors are still optimistic about this area, the future will still have more new investment enter the field. But it is suggested that enterprises those have plans to enter this industry have careful analysis of this market and the advantages or disadvantages of themselves.
The global Pulmonary Function Testing Systems market is valued at 340 million US$ in 2018 and will reach 470 million US$ by the end of 2025, growing at a CAGR of 4.2% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Pulmonary Function Testing Systems market based on company, product type, end user and key regions.
This report studies the global market size of Pulmonary Function Testing Systems in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Pulmonary Function Testing Systems in these regions.
This research report categorizes the global Pulmonary Function Testing Systems market by top players/brands, region, type and end user. This report also studies the global Pulmonary Function Testing Systems market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Market size by Product
Portable PFT Systems
Complete PFT Systems
Market size by End User
Physical Examination Center
Market size by Region
Central & South America
Rest of Central & South America
Middle East & Africa
The study objectives of this report are:
To study and analyze the global Pulmonary Function Testing Systems market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Pulmonary Function Testing Systems market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Pulmonary Function Testing Systems companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Pulmonary Function Testing Systems submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Pulmonary Function Testing Systems are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Pulmonary Function Testing Systems market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.